These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3920336)

  • 1. Storage iron exchange in the rat as affected by deferoxamine.
    Kim BK; Huebers H; Pippard MJ; Finch CA
    J Lab Clin Med; 1985 Apr; 105(4):440-8. PubMed ID: 3920336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE; Torrance JD; Bothwell TH; Simon MO; Charlton RW
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of transferrin saturation on internal iron exchange.
    Bergamaschi G; Eng MJ; Huebers HA; Finch CA
    Proc Soc Exp Biol Med; 1986 Oct; 183(1):66-73. PubMed ID: 3749034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte iron release in rats.
    Beguin Y; Huebers HA; Weber G; Eng M; Finch CA
    J Lab Clin Med; 1989 Mar; 113(3):346-54. PubMed ID: 2926242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R; Miller J; Crosby W
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C; Cook JD; Finch DA
    J Lab Clin Med; 1973 Jun; 81(6):876-86. PubMed ID: 4196982
    [No Abstract]   [Full Text] [Related]  

  • 9. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
    Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C
    Blood; 1978 Mar; 51(3):415-23. PubMed ID: 623907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism in the porphyrias.
    Turnbull A
    Br J Dermatol; 1971 Apr; 84(4):380-3. PubMed ID: 4930208
    [No Abstract]   [Full Text] [Related]  

  • 12. Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: studies of the chelatable iron pool by electron microscopy and Mössbauer spectroscopy.
    Shiloh H; Iancu TC; Bauminger ER; Link G; Pinson A; Hershko C
    J Lab Clin Med; 1992 Apr; 119(4):428-36. PubMed ID: 1583395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of iron excretion in relation to haemoglobin level and iron load in 8 haematological patients following the administration of subcutaneous deferrioxamine.
    Di Palma A; Moratelli S; Tolomelli P; Giuberti M; Tenan R; Fagioli F; Landi L; Toffoli C; Atti G; Vullo C
    Eur J Haematol; 1994 Oct; 53(4):197-200. PubMed ID: 7957802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine inhibition of malaria is independent of host iron status.
    Hershko C; Peto TE
    J Exp Med; 1988 Jul; 168(1):375-87. PubMed ID: 3294334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
    FIELDING J
    J Clin Pathol; 1965 Jan; 18(1):88-97. PubMed ID: 14247711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid assay for evaluation of iron-chelating agents in rats.
    Pippard MJ; Johnson DK; Finch CA
    Blood; 1981 Oct; 58(4):685-92. PubMed ID: 7272500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of iron and iron binding protein in abnormal iron metabolism--iron overload.
    Matsuda S; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1669-76. PubMed ID: 3564854
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors involved in the regulation of iron transport through reticuloendothelial cells.
    Siegenberg D; Baynes RD; Bothwell TH; MacFarlane BJ; Lamparelli RD
    Proc Soc Exp Biol Med; 1990 Jan; 193(1):65-72. PubMed ID: 2294524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.